A rapidly growing number of studies using inhibition of the contralesional hemisphere after stroke are reporting improvement in motor performance of the paretic hand. These studies have used different treatment onset time, duration and non-invasive methods of inhibition. Whereas these results are encouraging, several questions regarding the mechanisms of inhibition and the most effective treatment parameters are currently unanswered. In the present study, we used a rat model of cortical lesion to study the effects of GABA-mediated inactivation on motor recovery. In particular, we were interested in understanding better the effect of inactivation duration when it is initiated within hours following a cortical lesion. Cortical lesions were induced with endothelin-1 microinjections. The contralesional hemisphere was inactivated with continuous infusion of the GABA-A agonist Muscimol for 3, 7 or 14 days in three different groups of animals. In a fourth group, Muscimol was infused at slower rate for 14 days to provide additional insights on the relation between the effects of inactivation on the non-paretic forelimb behavior and the recovery of the paretic forelimb. In spontaneously recovered animals, the lesion caused a sustained bias to use the non-paretic forelimb and long-lasting grasping deficits with the paretic forelimb. Contralesional inactivation produced a general decrease of behavioral activity, affected the spontaneous use of the forelimbs and caused a specific reduction of the non-paretic forelimb function. The intensity and the duration of these behavioral effects varied in the different experimental groups. For the paretic forelimb, increasing inactivation duration accelerated the recovery of grasping function. Both groups with 14 days of inactivation had similar recovery profiles and performed better than animals that spontaneously recovered. Whereas the plateau performance of the paretic forelimb correlated with the duration of contralesional inactivation, it was not correlated with the spontaneous use of the forelimbs or with grasping performance of the non-paretic hand. Our results support that contralesional inactivation initiated within hours after a cortical lesion can improve recovery of the paretic forelimb. In our model, increasing the duration of the inactivation improved motor outcomes but the spontaneous use and motor performance of the non-paretic forelimb had no impact on recovery of the paretic forelimb.
Introduction
Several studies have shown that following a lesion, there is an increase of cortical excitability in the contralesional hemisphere (Meyer et al., 1985; Mohajerani et al., 2011; Sakatani et al., 1990) . The hyperexcitability in the contralesional cortex (Buchkremer-Ratzmann et al., 1996) is associated with a diminution of GABAergic inhibition (Witte and Stoll, 1997 ) and a reduction of GABA-A receptor binding (Lee et al., 2011; Qu et al., 1998) , suggesting that it may be related to a decreased potency of the inhibitory GABAergic system. Longitudinal imaging studies in humans have shown that the contralesional activity is typically maximal early after the injury and progressively diminishes with time and recovery (Carey et al., 2006; Jaillard et al., 2005; Marshall et al., 2000) .
In the last few years, several modulatory approaches using noninvasive stimulation techniques to favor adaptive plasticity and recovery after stroke have been proposed and are currently being tested. In particular, many groups are intensively investigating the effects of inhibition of the contralesional hemisphere on behavioral recovery (Hummel and Cohen, 2006) . The rationale behind the treatment strategy used in most studies is based on the concept of interhemispheric imbalance (Liepert et al., 2000; Nowak et al., 2009 ). According to this hypothesis, hyperexcitability in the contralesional hemisphere results in an augmented inhibitory influence on the ipsilesional hemisphere. In this manner, the contralesional hemisphere would interfere with function and adaptive plasticity in the ipsilesional hemisphere and with recovery of the paretic arm. However, this hypothesis is far from being universally accepted.
While some studies using protocols of inhibition of the contralesional cortex with non-invasive stimulation techniques show improvements in motor performance of the paretic hand (Khedr et al., 2009; Nowak et al., 2008; Takeuchi et al., 2005) , inhibition of contralesional areas with atypically high activity in chronic stroke patients is also shown to interfere with performance of the paretic hand (Johansen-Berg et al., 2002; Lotze et al., 2006) . To date, only a few studies have used multiple treatments sessions, many of them with different treatment duration and onset (Boggio et al., 2007; Fregni et al., 2006; Khedr et al., 2009 ). Therefore, the effect of inhibition duration on behavioral recovery is virtually unexplored. No study has yet has tested the effect of contralesional inhibition initiated within hours following the lesion, when the interhemispheric imbalance should be maximal. Moreover, the mechanisms through which non-invasive stimulation methods can induce cortical inhibition and to what extent they act through GABA are not fully understood, leaving open the question if potentiating GABA-mediated inhibition of the contralesional hemisphere can improve recovery.
To provide some insight on these issues, we used a well-established method of inactivation consisting of continuous infusion of the GABA-A agonist Muscimol (Martin, 1991 ) in a rat model of cortical lesion. In particular, our objectives were to confirm that GABA-mediated inactivation and very early inactivation could favor recovery, and to study the effect of duration of contralesional inactivation on motor outcomes. Of course, interpretation of our results and their translation to humans should be done with caution. The inherent differences in the methods used to inactivate the contralesional hemisphere in our model and humans, and the much longer durations and intensity of the inactivation we used, as revealed in the behavior of the non-paretic forelimb, should all be kept in mind.
These data increase our understanding of the basic interactions between inactivation of the contralesional hemisphere, behavior of the non-paretic forelimb and recovery of the paretic forelimb and may provide useful cues for the development of treatments based on contralesional inhibition after stroke.
Methods

Animals
A total of 53 Sprague-Dawley rats (Charles River, QC, CA) of approximately 2 months of age and weighing 250-300 g were included in the study. All animals were housed in solitary standard Plexiglas cages with reverse day-night cycle (7 am-7 pm). They were handled only during the dark cycle. Upon their arrival at our facility, animals were familiarized with banana food pellets in the Montoya staircase test (Biernaskie and Corbett, 2001; Montoya et al., 1991) for 10 work-days (Fig. 1) . To incite reaching behavior in the Montoya test, food access was carefully monitored during the two weeks of familiarization. For each rat, the daily food minimum corresponded to 5% of its body weight. Rats had free access to 85% of their daily minimum in the home cage. They could obtain more food to surpass the 100% value in the Montoya staircase apparatus. On any given day, if the animal did not attain its daily minimum in the Montoya, additional food was supplied in its home cage to reach the daily minimum. Baseline data were collected at the end of the familiarization period. Spontaneous use of forelimbs in exploratory behavior was documented with the cylinder wall test and grasping function with the Montoya Staircase test (Montoya et al., 1991) . Animals that performed above the inclusion criteria (see Montoya Staircase test below) were randomly assigned to an experimental group. During the post-lesion period, food was restricted for 12-14 h prior to each behavioral testing session and animals were given free access to food after testing. The weight of the animals was recorded daily during the 2 weeks prior to the lesion and weekly after the lesion. If an animal lost more than 10% of its original body weight at any point during the experiment, it was excluded. Two animals from Group 14D were excluded from the study during the recovery period because of weight loss and seizures. Animals had ad libitum access to water at all times. Our experimental protocol followed the guidelines of the Canadian Council on Animal Care and was approved by the Comité de Déontologie de l'Expérimentation sur les Animaux of the Université de Montréal.
Cylinder test: measurement of spontaneous forelimb use
To detect spontaneous asymmetrical use of forelimbs, rats were placed in a transparent cylinder of 19 cm diameter and 33 cm height for 3-30 min or until 60 touches to the cylinder wall was achieved . Animals were videotaped from above using a high definition digital video camera (30 frames/s). The videos were analyzed frame-by-frame offline to count the use of paretic versus non-paretic limbs during vertical exploration of the cylinder wall. The forelimb asymmetry score was calculated using the following equation:
Asymmetry score ¼ touches with paretic forelimb−touches with nonparetic forelimb total number of touches
Montoya Staircase test: Grasping and retrieving performance
Rats were placed in a Plexiglas chamber (6-cm wide, 12-cm high and 30-cm long) with a central platform (2.3-cm wide, 6-cm high and 19-cm long) that supports the weight, separating the right and left forelimbs (Biernaskie and Corbett, 2001; Montoya et al., 1991) . A pair of staircases with seven steps on each side was loaded into the Plexiglas chamber on both sides of the central platform. Each step had a smooth well that can hold one to three standard 45 mg banana flavored food pellets (Bioserve Inc., Frenchtown, NJ, USA). During the familiarization period, animals had a session of Montoya staircase in the morning and one in the afternoon, the two separated by 3 to 4 h. In a session, the rats had 4 trials with each hand (8 trials per day in total). Initially, for each trial, every well on one side of the staircase was filled with 3 food pellets and 15 min were given to retrieve the pellets. In the following days, the number of pellets in each well and the time provided was progressively tapered according to the performance of the rat. However, by the 8th day, only one pellet per well and 3 min per trial were given to all rats. On the 9th and 10th days of the familiarization period, the performance in terms of the number of eaten pellets was recorded and used to establish if the animal reached our inclusion criteria. To be included in the study, rats needed to eat 4 out of 7 pellets in 3 of the 4 trials on both days with one of the two arms. Based on these criteria, 9 animals were excluded from the study. The lesion was induced in the cortex contralateral to the arm with the best performance score.
Surgical procedures
All surgical procedures were conducted aseptically. Anesthesia was induced with Ketamine (80 mg/kg, intra-peritoneal) and maintained with isoflurane (~2% in 100% oxygen) delivered via a custom-made facial mask adapted to our stereotaxic frame. Pulse rate and oxygen saturation were monitored and documented during the surgery. A self-regulating heating blanket (Harvard Apparatus, Holliston, MA) was used to maintain body temperature during the surgery. A midline incision was made to expose the skull and neck muscles. A small incision was made between C0 and C1 to release cerebrospinal fluid of the cisterna magna and reduce intracranial pressure.
In order to confirm the location of the motor areas of 3-month-old Sprague Dawley rats, we conducted intracortical microstimulation (ICMS) mapping experiments in naïve animals (n = 3) (Fig. 1B) . Following craniotomy and durectomy, anesthesia was switched to ketamine hydrochloride (~10 mg/kg/10 min; intraperitoneal) for the collection of electrophysiological data. A glass coated tungsten microelectrode (~1 MΩ) was used for electrical stimulation applied at a depth of~1600 μm. Stimulation consisted of a 40 ms train of 13 monophasic cathodal pulses of 200 μs delivered at 350 Hz from an electrically isolated, constant current stimulator (Dancause et al., 2006; Nudo et al., 1992 Nudo et al., , 1996 . Pulse trains were repeated at 1 Hz intervals; current was ≤ 100 μA. Microelectrode interpenetration distances were~333 μm. Stimulations were done to identify the caudal and rostral forelimb areas (CFA and RFA). The two areas were typically separated with neck and vibrissa representations. Based on ICMS maps, we selected the stereotaxic coordinates for six injections of endothelin-1 (ET-1) as in Fang and collaborators (Fang et al., 2010) (Fig. 1C) . ICMS mapping was conducted in additional animals (n = 3) at the end of the recovery period (day 60 after the lesion) and confirmed that the lesion destroyed a large portion of the CFA and appeared to leave the RFA intact (Fig. 1B) .
To induce the cortical lesion, six 0.6-mm holes were drilled over the caudal forelimb area (CFA) based on stereotaxic coordinates (+ 1.5, + 0.5, − 0.5 mm anteroposterior, + 2.5, + 3.5 mm mediolateral to bregma; Fig. 1B) (Fang et al., 2010) . Using a 1 μl Hamilton syringe, a microinjection of endothelin-1 (ET1) (EMD chemicals, CA, USA) was made in each hole at a depth of 1.5 mm in the cortex (0.33 μl, 0.3 μg/μl, 3 nl/s). Following each injection of endothelin-1 (ET-1), the holes were sealed with bone wax. After the lesion induction, an additional 0.6-mm hole was drilled over the center of the contralesional CFA (+0.5 mm anterior and +3 mm lateral to bregma). A cannula (0.36 mm, brain infusion kit 1; Alzet, CA, USA) was implanted at the depth of 1.5 mm below the cortical surface and secured in place with acrylic cement (Fig. 1D) . The cannula was connected to an osmotic pump filled with Fig. 1 . Experimental design. A) Time course of events in reference to the lesion. Baseline data were collected on the 9th and 10th days of the familiarization period and averaged to establish a baseline performance score. Following the cortical lesion, data were collected twice in the first week, on days 4 and 7, and then once per week until day 56. Horizontal bars in the intervention period show the duration of inactivation in different experimental groups. B) Location of ET-1 lesion in relation to motor representations. The top panel shows a typical ICMS map in a naïve animal of comparable age and weight to animals used in the present study. Contours outline the caudal forelimb area (CFA; red) and the rostral forelimb area (RFA; orange). Each dot is a penetration site where microstimulations were delivered. Bottom panel shows an example of the impact of the ET-1 lesion in a rat that spontaneously recovered for 56 days (Group Lesion no pump ). The lesion was in the CFA and spared the RFA. Muscimol (10 mM, Tocris Bioscience, Bristol, UK), a non-toxic GABA-A agonist. Muscimol was chosen because it is a well-established and simple way to reliably inactivate neural tissue for sustained periods without causing damage (Martin, 1991; Reiter and Stryker, 1988) . Neck muscles were then glued back with dermal adhesive and the skin sutured. After the surgery, animals received a regimen of pain, anti-inflammatory and antibiotic medication and their recovery was closely followed.
Experimental groups
In 3 different experimental groups (Table 1) , the contralesional hemisphere was inactivated for 3, 7 or 14 days with infusion of Muscimol (10 mM) at a rate of 0.5 μl/h (Groups 3D, 7D and 14D) beginning within 2 h following the lesion. An additional group (Group 14D slow ) also received 14 days of Muscimol infusion, but delivered at a slower rate (0.25 μl/h). Because no pump model could provide infusion of 3 days, the plastic tube between the pump and the cannula was cut and sealed in a minor procedure 72 h after the lesion in Group 3D.
With our method of inactivation, the main concern was that the lesion made by the cannula affected the behavior of the non-paretic forelimb. Therefore, in control animals (Group Lesion no pump ), to reproduce the mechanical damage caused by the cannula, a stainless steel rod of the same diameter as the cannula was lowered at a depth of 1.5 mm and immobilized in acrylic. To rule out the possibility that vehicle infusion in the contralesional hemisphere affected behavior, a pump infusing saline (0.5 μl/h) for 14 days was implanted after the cortical lesion in additional control rats (n = 3). No statistical difference of performance on the Montoya staircase tests was found between the two control groups (One way ANOVA paretic hand F = 0.10; p = 0.76; non-paretic hand F = 0.23 p = 0.64). Thus, as in intact animals (Martin et al., 2000) , vehicle infusion in the contralesional motor cortex with these methods does not affect behavior. On post-lesion day 56, the animal was killed, the brain fixed, cryoprotected and cut coronally for anatomical reconstruction and estimation of the lesion size (MicroBrightField, VT, USA).
Reversible inactivation using Muscimol infusion of long duration
The effects of chronic brain inactivation using GABA-A agonist Muscimol on neural activity and behavior have been carefully documented (Hata and Stryker, 1994; Martin, 1991; Martin and Ghez, 1999; Reiter and Stryker, 1988) . In kittens, recording of neural activity in the visual cortex following infusion with osmotic pumps for 8 to 11 days with parameters similar to the ones we used (0.5 μl/h of 10 Mm) showed that inactivation extended over a radius of 1 to 3.5 mm (Reiter and Stryker, 1988) . To confirm that our injection protocol resulted in comparable spread, we filled the osmotic pump with Fluorophore-conjugated Muscimol molecule (BODIPY® TMR-X conjugate; Molecular probes). We infused fluorescent Muscimol at 0.5 μl/h for 3 days in one animal (Group 3D; Fig. 2A ), for 7 days (Group 7D; Fig. 2B ) in one animal and for 13 days (Group 14D; Fig. 2C ) in one animal. Whereas the pump model infuses for 14 days, we chose to perfuse on day 13 to insure the infusion was still at its maximum. Finally we infused fluorescent Muscimol at 0.25 μl/h in one animal for 13 days (Group 14D slow ; Fig. 2D ). Following the infusion period, animals were perfused, and the tissue processed according to an established protocol using this product (Allen et al., 2008) . Coronal sections were inspected Fig. 2 . Spread of muscimol infusion in different experimental groups. We infused fluorophore-conjugated Muscimol to evaluate the spread of muscimol in our different experimental groups. Coronal sections of animals in which Muscimol was infused for A) 3 days at 0.5 μl/h (Group 3D), B) 7 days at 0.5 μl/h (Group 7D), C) 14 days at 0.5 μl/h (Group 14D) and D) 14 days at 0.25 μl/h (Group 14D slow ) are shown. We found that the radius of diffusion was less than 2 mm in all animals. Scale bar = 5 mm.
using a Cy3-4040C BrightLine filter on a BX51 Olympus microscope with a 10× objective. On each section where the fluorescent Muscimol was visible, digital photographs of the entire contralesional hemisphere were taken. Aperture and exposure were kept constant between sections and animals. Digital pictures were imported and aligned in Adobe Photoshop (Adobe Systems, San Jose, CA). To identify the spread of the fluorescence on each section, brightness was decreased. This typically facilitated the identification of a dense core and a narrow halo. In both these regions, the fluorescence was opaque and the details of the tissue difficult to see. Around the core and halo, often, another transition zone was visible. In this region, the tissue was only slightly brighter than the general background. The details of the tissue were discernable in this area. We included only the core and the narrow halo in our calculation of the spread of Muscimol. The limits were identified by one evaluator and confirmed by a second that was blinded to the infusion protocol used for the animal. We first found the coronal section with the maximal medio-lateral radius of the Muscimol spread and measured its radius (ML radius). Then, the anteroposterior (AP) radius was calculated from the span of sections showing the fluorescence AP radius ¼ n Â 40 μm thick section Ä 2 where n = the number of sections with fluorescent Muscimol.
For each animal, the diffusion radius was the average of the ML and AP radii.
We found that Groups 3D and 7D had identical diffusion radius (1.2 mm). Group 14D slow had the smallest (1.1 mm) and Group 14D the largest radius (1.9 mm) of Muscimol diffusion. However, these differences are small and their significance questionable considering the variability of the diffusion radius reported by others (Reiter and Stryker, 1988) . Thus, analyses and conclusions in the present set of experiments are based on the behavioral effect of the inactivation on the non-paretic forelimb and not on the rate of infusion or hypothetical radius of inactivation.
To show that in our model, Muscimol effectively induced a reversible contralesional inactivation and did not cause permanent damage to the contralesional hemisphere, we conducted a series of controls. First, we conducted ICMS mapping in the contralesional hemisphere at the end of the recovery period in one animal of Group Lesion no pump , Group 7D and Group 14D (Fig. 3) . We found that we could evoke movements from the cortex immediately surrounding the cannula using normal current intensity and could not differentiate the responses in the animals that received Muscimol from the Lesion no pump or from naïve animals. We also visually inspected the Nissl stained tissue around the cannula in all of our animals and found no differences between experimental groups (Fig. 4) . To further confirm this finding, we calculated the size of the lesion made by the cannula in the contralesional hemisphere in Nissl-stained sections for Groups 14D and 14D slow , the two groups with Muscimol infusion of the longest duration, and compared it to the lesions made by the metal rod in Group Lesion no pump . In the contralesional hemisphere, the cannula made a small mechanical lesion in all groups. On average for Groups Lesion no pump , 14D and 14D slow , the lesion made by the cannula was 0.15 mm 3 , corresponding to 1.6% of the volume of the ET-1 lesion. A one-way ANOVA between the three groups found no significant difference (F = 2.15, p = 0.16) and, combining Groups 14D + 14D slow and comparing the lesion size to the Group Lesion no pump also did not show any difference (t-test; equal variance not assumed: F = 0.88, p = 0.40).
Altogether, these data support that Muscimol transiently inactivated the contralesional hemisphere and did not result in any permanent damage in our experimental groups. Thus, whereas there is permanent damage to the contralesional hemisphere, it was a small mechanical damage caused by the insertion of the Fig. 3 . Responses to intracortical microstimulation (ICMS) following sustained muscimol infusion. At the end of the recovery period, we derived motor maps in the contralesional hemisphere using ICMS in A) one animal from Groups Lesion no pump , B) one animal from Group 7D and C) one animal from Group 14D. In all cases, only a small cortical lesion was visible on the surface of the cortex (asterisk). Evoked movements are color-coded and the two motor representations, the caudal (CFA) and the rostral forelimb area (RFA), are outlined. We found that the tissue in the CFA was responsive to stimulation, with no apparent difference between the animals. These data support that sustained infusion of Muscimol did not result in permanent damage of the tissue. D) ICMS map of the animal from Group 14D on which the range of Muscimol diffusion we found is superimposed (see Fig. 2 ). Circles show the smallest (1.1 mm, Group 14Dslow) and largest radius (1.9 mm, Group 14D) of fluorescent Muscimol spread.
cannula that was of identical size across experimental groups and controlled for in our Group Lesion no pump .
Histology and anatomical reconstruction
At the end of the experiments, animals were given a lethal dose of sodium pentobarbital and were transcardially perfused with heparinized 0.1 M phosphate buffered saline (PBS) followed by 4% paraformaldehyde in 0.1 M PBS. Brains were extracted and post-fixed in 4% paraformaldehyde. The brains were cryoprotected in a solution of 20% sucrose and 2% dimethyl sulfoxide (DMSO) over-night followed by 20% sucrose for 48 h and quickly frozen at −55°C utilizing methyl butane and stored at − 80°C (Brocard et al., 2010) . Coronal sections were cut with a cryostat (40 μm thickness). One out of six sections was Nissl stained and used for analysis of the lesion size and location. The lesion size was calculated with a software (MicroBrightField, Colchester, VT, USA) using the following formula:
Lesion size % ð Þ ¼ volume of contralesional cortex−volume of ipsilesional cortex volume of contralesional hemisphere Â 100
Statistical analysis of experimental results
All values are reported as mean ± SEM, unless specified, and significance was considered at p b 0.05. Lesion volume between groups of animals was compared with a one-way ANOVA. For the Cylinder and Montoya tests, two repeated measures ANOVAs were conducted using animal group, time and group x time as factors and Tukey-HSD for post-hoc testing. Pre-lesion baseline data and post-intervention recovery period data (day 21 to 56 post-lesion) were included in this analysis. Statistical analysis during the intervention period was impossible because behavioral data could not be collected in all animals (see Results section).
Mixed modeling, adjusting for correlations between individual measurements over time, was conducted to identify the plateau performance of the paretic limb on the Montoya test. Regressions were used to investigate how different factors correlated with this plateau performance for each rat. The autoregressive correlation structure, which indicates that for each individual, observations taken close in time tend to be more highly correlated than observations taken far apart in time, was assumed in the analysis. To avoid making unfounded assumptions on the shape of the effect of time, we treated time as a categorical variable in the analysis. Regression results report the Spearman's correlation coefficient and t-test on the slope of the distribution. Statistical significance for the t-test was adjusted according to the Bonferroni correction factor (p b 0.017).
Results
Cortical lesions
The average ET-1 induced lesion volume was 6.8 ± 2.5 mm 3 (Mean ± standard deviation). As reported by others using a similar ET-1 lesion protocol (Fang et al., 2010) , lesions destroyed all cortical layers and there was no significant difference of lesion size between experimental groups (F = 0.206, P = 0.892) (Fig. 5) . 
General behavior during the intervention period
During the infusion of Muscimol, rats were typically much less active. Some rats made no movement in the Montoya staircase tests (Fig. 6) . In Group 3D, some rats were still inactive at day 7 after the lesion, showing that the reversal of the effects of inactivation took more than four days in some cases. Groups 7D and 14D were more severely affected. More than half of the animals in these groups were inactive in the Montoya staircase in the first week during infusion of Muscimol. The side effects of Muscimol became problematic with time for some animals of Group 14D, and two rats from this group had to be excluded (see Methods section). Using a slower rate of infusion (Group 14D slow ) diminished the inactivity caused by infusion of Muscimol. In fact, the general behavior of animals from Group 14D slow was the least affected by Muscimol delivery, supporting that the rate of infusion had a greater influence on these deleterious effects than the duration of inactivation.
The effect of inactivation on grasping performance of the non-paretic forelimb
The animals receiving Muscimol showed signs of impairments of grasping performance with the non-paretic forelimb in the Montoya test, confirming the effectiveness of the pharmacological agent. The analysis of the performance of the non-paretic forelimb in the Montoya test was done on the baseline and the post-intervention recovery period to include all animals in each group. The ANOVA showed a significant effect of group (F = 9.237, P b 0.001), time (F = 49.244, P b 0.001), and time × group (F = 11.034, P b 0.001). The pre-lesion performance was similar between all groups. In Group Lesion no pump , the ET-1 lesion and the mechanical damage caused by the metal rod did not decrease the performance of the non-paretic forelimb to a significant level (Fig. 7) . In Groups 3D and 7D, whereas inactivation affected grasping during the intervention period, performance was not statistically different from pre-lesion baseline or from Group Lesion no pump in the post-intervention recovery period. The effect of inactivation on the non-paretic forelimb function of animals in Group 14D was strikingly different. Grasping performance was significantly lower than prelesion baseline and from Group Lesion no pump until the 35th day after the lesion. Thus 14 days of inactivation resulted in behavioral impairments of the non-paretic forelimb that lasted more than 2 weeks after the end of infusion. Using a slower infusion rate for 14 days in Group 14D slow did not affect the level of impairments on grasping performance caused by the inactivation. Together with results from Fig. 6 , these data show that a slower rate of infusion had less detrimental effects on the general state of the animals but still had a comparable impact on the function of the non-paretic forelimb.
The effect of inactivation on spontaneous use of forelimbs
Rats also reared less often during the infusion of Muscimol. This was particularly true for animals in Groups 7D and 14D and less in Groups 3D and 14Dslow (missing data points in Fig. 8 ). We found that animals either did not touch the cylinder wall at all or when they did explore, we Fig. 6 . Side effects of contralesional inactivation. During Muscimol delivery the different experimental groups showed variable degrees of inactivity in the Montoya staircase test. Rats were given 15 min in the Montoya to perform the task for each trial. The graphs show the percentage of animals in each experimental group that were inactive in the test for that entire period and from which no behavioral data could be collected. Fig. 7 . Non-paretic forelimb grasping performance on the Montoya test. The intervention period is highlighted with gray background. In this period, data points with n ≥ 5 are shown even if they were not included in the statistical analyses. Inactivation in Group 14D resulted in sustained deficits of the non-paretic forelimb until day 35 after the lesion. Slower infusion rate (Group 14D slow ) induced similar deficits. Symbols show significant differences from Group Lesion no pump . Fig. 8 . The effect of inactivation on spontaneous use of forelimbs. Laterality scores in the cylinder test. Positive values highlight an increased use of the paretic forelimb in relation to the pre-lesion behavior of the animal. During the infusion period, data points with n ≥ 5 are shown even if they were not included in the statistical analyses. In Group Lesion no pump , the lesion caused a bias for the non-paretic forelimb. In contrast, inactivation in Groups 7D, 14D and 14Dslow resulted in a bias to use the paretic forelimb. The laterality index in Group 14D was significantly different from Group Lesion no pump throughout recovery. Symbols show significant differences from Group Lesion no pump .
obtained a large number of touches. In only 5 rats, we obtained one data collection session with less than 55 touches, but more than 22. We considered that more than 20 touches were sufficient to provide an average for that session and thus included that session in the group average. Four of these 5 sessions were during the infusion of Muscimol and thus, were not included in the statistical analyses. In all other data collection sessions (n = 457), we obtained more than 55 touches. Thus, the laterality scores obtained for each rat, in any session, are robust.
Analysis of the spontaneous use of the forelimbs in the cylinder test was done for the post-intervention recovery period and includes all animals in each group. The ANOVA showed a significant effect of group (F = 32.549, P b 0.001) and group × time (F = 4.338, p b 0.001). After the cortical lesion, animals in Group Lesion no pump used their non-paretic forelimb more often throughout the postintervention recovery period (Fig. 8) . Thus, the lesion created a persistent bias for the use of the non-paretic forelimb. Following inactivation of short duration (Group 3D), there was an initial bias toward the use of the non-paretic forelimb. However, the animals recovered symmetrical use of their forelimbs at day 28. Inactivation of longer duration caused an initial bias to use the paretic forelimb. Whereas animals in Group 7D returned to symmetrical use of their forelimb by day 28, the bias for the paretic forearm persisted until day 35 in Group 14D. The laterality index of Group 14D was different from controls throughout recovery. The use of a slower infusion rate for 14 days in Group 14D slow still resulted in a bias to use the paretic forelimb on day 21. However, the animals returned to a symmetrical forelimb use during spontaneous exploration on day 28 and their laterality index was not different from Group Lesion no pump , much like for Groups 3D and 7D.
The effect of inactivation on post-intervention recovery of the paretic forelimb
In the Montoya staircase test, grasping performance of the paretic forelimb showed a significant effect of group (F = 6.016, P b 0.001), time (F = 49.528, P b 0.001) and time × group (F = 5.739, P b 0.001). Pre-lesion performance was similar among all experimental groups (Fig. 9) . The Group Lesion no pump had significant deficits until the 56th day after the lesion. Inactivation of the contralesional hemisphere initially worsened the paretic forelimb function during the intervention period but then improved it in the post-intervention recovery period. Groups 3D and 7D recovered faster from the lesion than Group Lesion no pump . They reached pre-lesion performance at days 35 and 28, respectively, and Group 7D transiently performed better than Group Lesion no pump on day 28. Group 14D had significant deficits and poorer performance than other groups on day 21. However, by day 28 and for the rest of the post-intervention recovery period, these animals had no deficits and performed significantly better than Group Lesion no pump . Grasping performance of Group 14D slow was similar to other groups and better than Group 14D on day 21. This group performed better than Group Lesion no pump from days 28 to 49. Thus, the beneficial effects of inactivation on recovery of the paretic forelimb were mostly preserved when a slower infusion rate was used to inactivate the contralesional hemisphere for 14 days. These results support that the beneficial effect of contralesional inactivation depends mainly on the duration of the inactivation and not the rate of infusion.
The effect of non-paretic forelimb behavior and inactivation duration on final level of recovery
We found that plateau performance on the Montoya test for the paretic limb was reached at day 7 for Group Lesion no pump , day 21 for Group 3D, day 28 for Group 7D and day 35 for Groups 14D and 14D slow . Thus, from day 35 to day 56, all groups had a stable level of performance. For each animal, we calculated the average Montoya score between days 35 and 56 to obtain a 'plateau performance score'. Three regressions were conducted to study factors potentially correlating with the plateau performance score.
First, we performed a regression between the asymmetry score on the Cylinder test at day 21 and the plateau performance score for each animal (Fig. 10A) . A positive correlation between these factors would suggest that increased spontaneous use of the paretic forelimb at the beginning of the post-intervention recovery period results in better recovery of the paretic forelimb. We found a weak correlation between the two factors (R = 0.28) and a non-significant slope of the distribution (p = 0.13).
Second, we performed a regression analysis between the Montoya score of non-paretic forelimb at day 21 and the plateau performance score of the paretic forelimb (Fig. 10B) . Here, a negative correlation between these factors suggests that poor performance of the nonparetic forelimb at the beginning of the post-intervention period results in better recovery of the paretic forelimb. We found a weak negative correlation between the two factors (R = − 0.12) and a nonsignificant slope of the distribution (p = 0.58).
A third regression was conducted between the inactivation duration value (0, 3, 7, 14) and the plateau performance score to test how well the inactivation duration correlated with the level of recovery (Fig. 10C) . A positive correlation between these factors suggests that a longer duration of inactivation results in better recovery of the paretic forelimb. The correlation between the two factors was higher than other variables tested (R = 0.52) and the slope of the distribution was highly significant (p = 0.0004). Overall, the correlation analyses suggest that the level of recovery was weakly influenced by the spontaneous use of forelimbs or on grasping function of the nonparetic forelimb after inactivation of the contralesional hemisphere. In contrast, the duration of inactivation had a great impact.
Discussion
We used a rat model of cortical lesion to study the basic interaction between GABA-mediated inactivation of the contralesional hemisphere and behavioral recovery. Inactivation was initiated rapidly following the lesion and was maintained for increasing durations in different groups Fig. 9 . Effects of inactivation on the recovery of the paretic forelimb. Grasping performance of the paretic forelimb in the Montoya test. Group Lesion no pump recovered to baseline level only by day 56. The performance was worsened by the inactivation during the intervention period. However, in the post-intervention recovery period, animals with inactivation recovered better than controls. Symbols show significant differences from Group Lesion no pump . of animals. During the Muscimol delivery period, inactivation resulted in general inactivity of the animals, impaired the use of the nonparetic forelimb and worsened the function of the paretic forelimb. These effects were much greater than what is induced with noninvasive stimulation methods in humans, something that should be kept in mind when interpreting the results. In the post-intervention recovery period, the adverse effects of inactivation progressively reverted. Rats with inactivation of the contralesional hemisphere recovered their grasping skills faster than untreated animals and the time of recovery was shorter for animals with inactivation of longer duration. In comparison to controls, the grasping function of the paretic forelimb showed a tendency to be greater following inactivation of longer durations. In rats with 14 days of inactivation, this trend reached significance four weeks after the lesion and remained significant for the rest of the experiment. Using a slower infusion rate to inhibit the contralesional hemisphere for 14 days diminished the deleterious effect on the general behavior during inactivation while still preserving most of the beneficial effects on chronic recovery. Final recovery scores were correlated to the duration of inactivation but not to the spontaneous use of the forelimbs or the function of the non-paretic forelimb.
In our model, we found that acute inactivation of the contralesional hemisphere can favor recovery of the paretic forelimb. Inactivation of longer duration results in more pronounced and sustained recovery of function. Final recovery is more affected by the duration of inactivation than on the effects of inactivation on general behavior or on the nonparetic forelimb.
Spontaneous recovery following ET-1 lesions in the sensorimotor cortex of rats
Cortical microinjections of ET-1 are now a common approach to produce focal cortical lesions in rats (Windle et al., 2006) . As shown by others using similar lesion protocols, we found relatively small variability in lesion size among animals, facilitating comparison of behavioral recovery between experimental groups (Fang et al., 2010) .
In spontaneously recovering animals, the Group Lesion no pump in the present study, lesions caused typical motor deficits of the paretic forelimb. The Cylinder and Montoya tests both revealed initial deficits of the paretic forelimb that recovered in the first 3 weeks. The recovery then slowed to reach a plateau and animals had small but persistent long-term deficits (Biernaskie and Corbett, 2001) .
For the non-paretic forelimb, we found no change of performance in the Montoya test after lesion. Together with Cylinder test results, our data confirm that the mechanical damage caused by implantation of the cannula did not affect the function of the non-paretic forelimb.
Effects of GABA-mediated inactivation on general behavioral inactivity
We inactivated the contralesional hemisphere with chronic infusion of the GABA-A agonist Muscimol. This method has carefully documented effects on neural activity and behavior. With the parameters of infusion we used to test the effect of duration on recovery (10 mM, 0.5 μl/h) for 8 to 11 days, Muscimol was shown to inhibit activity within a radius of 1 to 3.5 mm from the cannula (Reiter and Stryker, 1988) . Using fluorescent Muscimol, we found that the radius of diffusion in our experiments had similar values, ranging from 1.1 mm (Group 14D slow ) to 1.9 mm (Group 14D). In animals of Groups 3D, 7D and 14D, the Muscimol appeared to diffuse further below the cortex, affecting the callosum and the dorsal striatum (Fig. 2) . In Group 14D slow, Muscimol appeared to be limited to the cortex. It is thus possible that the general inactivity, which we found to be the lowest in Group 14D slow , is a result of a spread of Muscimol to these additional structures. However, such conclusions must be taken with caution and warrant more data, specifically knowing the variability of Muscimol diffusion reported by others using similar techniques (Reiter and Stryker, 1988) . The level of general behavioral inactivity of the animal caused by Muscimol infusion after cortical lesion could have influenced the level of recovery of the paretic limb. However, using a slower infusion rate for 14 days (Group 14D slow ) was less detrimental to the general behavioral activity than 3 days of inactivation using the faster infusion rate (Group 3D). As the recovery of the paretic limb was comparable in Groups 14D and 14D slow (Fig. 9) , respectively the group with the most and least pronounced effects on general behavioral inactivity (Fig. 6 ), it appears that this inactivity has little effect on the recovery of the paretic forelimb.
Effects of GABA-mediated inactivation on the function of the non-paretic forelimb
In kittens, after sustained inhibition that lasts for 30 days, there is no injury to the inhibited tissue and grasping function returns to normal within 2-3 days (Martin et al., 2000) . In adult rats following cortical lesions, we found that similar parameters of Muscimol infusion resulted in more sustained behavioral deficits of the non-paretic forelimb. Following 14 days of inactivation, animals had significantly poorer grasping performance with the non-paretic forelimb 3 weeks after the end of Muscimol delivery. It is possible that the volume of inactivation in relation to the small brain size of the rat caused these effects. An alternative explanation may be that the cortical lesion potentiated the effects of inactivation in the contralesional hemisphere. It is well known that lesions trigger multiple changes in the contralesional cortex (Buchkremer-Ratzmann et al., 1996; Jones and Schallert, 1994) , some of which can increase skill learning of the non-paretic arm (Bury and Jones, 2002) . Acute inhibition of this hemisphere after a lesion could have a particularly stable impact on the non-paretic forelimb. In humans, it may prevent patients from developing useful compensatory strategies with the non-paretic forelimb, something that should be investigated further.
The sustained functional impact on the non-paretic forelimb caused by the 14 days inactivation raises a fundamental question. Are functional gains of the paretic forelimb due to central effects of the inhibition, increased use and practice with the paretic forelimb or a reversal of learned non-use (Taub, 2000) ? This issue cannot be completely addressed with the present data. However, our regression analyses show that the spontaneous use and grasping function of the nonparetic forelimb were poorly correlated to the recovery of the paretic forelimb. In contrast, duration of inactivation was highly correlated with the final level of recovery, suggesting that inhibition duration is much more critical and thus that central mechanisms were more involved in the recovery of the paretic forelimb. Following lesions in the CFA, increased use and motor learning with the non-paretic forelimb can decrease the recovery of the paretic arm (Allred and Jones, 2008; Allred et al., 2005) . The adverse effects of the non-paretic forelimb behavior on recovery are not seen in animals that sustain a bilateral CFA injury or a partial callosal transection (Allred et al., 2010) . These data suggest that the negative effect of the non-paretic forelimb training is mediated through the contralesional cortex and its callosal interactions with the ipsilesional hemisphere. Similarly, it is possible that the inactivation in our model improved non-paretic forelimb recovery by limiting the interhemispheric influence of the contralesional CFA on the ipsilesional hemisphere.
Finally, it is worth mentioning that the effects on general motor behaviors or on the non-paretic forelimb we found have not been reported in human studies using inhibition of the contralesional hemisphere after stroke. These results support that in our model, not only was the duration of inactivation longer, but inactivation was also more profound than what has been used so far in human protocols. These differences should be taken into consideration in the interpretation of the results. However, the improved recovery of the paretic forelimb, and the absence of long-term adverse effects in any of our experimental groups, suggest that inhibition of longer duration and higher intensity could be beneficial.
The effects of inactivation duration on the recovery of grasping function of the paretic forelimb
In humans, hyperexcitability of the contralesional hemisphere has been shown in several studies and is generally attributed to GABA down regulation (Butefisch et al., 2003) . In rodents, there is a rapid increase of somatosensory evoked potentials in the contralesional cortex (Sakatani et al., 1990) . After a few days, the contralesional hyperexcitability (Buchkremer-Ratzmann et al., 1996) is associated with a reduction of GABA-A receptors (Qu et al., 1998) . According to the interhemispheric imbalance hypothesis, the contralesional hyperexcitabilty is thought to contribute to ipsilesional diaschisis and to interfere with recovery of the paretic forelimb through an increase of interhemispheric inhibition (Liepert et al., 2000; Nowak et al., 2009) .
In the present study, inactivation of neural activity in the contralesional hemisphere with a GABA-agonist initially resulted in a decrease of function of the paretic forelimb. Similar short-term detrimental effects to the paretic forelimb have been reported in mice after traumatic cortical injury (Lee et al., 2011) . In our study, following recovery for a longer period, we found that these detrimental effects are transient. All experimental groups showed that GABA-mediated inactivation of the contralesional hemisphere initiated rapidly after the lesion can improve the rate and/or extent of recovery of the paretic forelimb.
In the present experiments, we chose to initiate contralesional inactivation within hours following the lesion. Longitudinal imaging studies in humans show that the increased contralesional activity is at its highest early after the lesion and is progressively resorbed with time and recovery (Jaillard et al., 2005; Marshall et al., 2000) . Accordingly, inhibition of the contralesional hemisphere early after lesion should be most beneficial to recovery. Only a few human studies have initiated treatment within the first week following stroke and their results indicate an improvement of recovery of the paretic forelimb (Khedr et al., 2009 (Khedr et al., , 2010 . However, early interventions, such as forced-use of the paretic forelimb, can increase functional deficits , raising doubts on how early any intervention should be initiated after lesion. In our model, results suggest that initiating inactivation of the contralesional hemisphere within hours following the lesion has no long-term detrimental effect on recovery of the paretic forelimb, regardless of inactivation duration.
In humans, studies using a single inhibition treatment appear to have short-lasting effects (Mansur et al., 2005; Nowak et al., 2008; Takeuchi et al., 2005) in comparison to treatments using multiple sessions (Emara et al., 2010; Fregni et al., 2006) . However, to date, there has been no systematic investigation of treatment duration on motor outcomes. The comparison of Groups 3D, 7D and 14D conveys a compelling message that increasing contralesional inactivation duration promotes recovery of the paretic forelimb. Of course, due to numerous differences such as the method of inhibition and limitations of our animal model, absolute numbers for treatment duration in stroke patients using non-invasive methods of inhibition cannot directly be inferred from our data. However, it is interesting to note that the most beneficial treatment was of 14 days, a period that corresponds to the time during which most of the spontaneous recovery occurs in our model. In humans, this period of faster recovery is of approximately one month, independently of the initial level of impairments (Duncan and Lai, 1997) . To date, treatment durations in human studies have all been much shorter than this critical period. Whereas our data do not resolve the issue of inhibition duration in humans after stroke, they do strongly indicate that duration is a crucial factor to consider in treatment design. 
